Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Choline Chloride
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Protara Aligns with FDA on Registrational Path Forward for IV Choline Chloride
Details : IV Choline Chloride is an investigational, intravenous phospholipid substrate replacement therapy initially in development for patients with Choline deficiency receiving parenteral nutrition (PN).
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 05, 2024
Lead Product(s) : Choline Chloride
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?